Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (171-180 of 308) with videos related to

Pageof 31
Sort By:
Pilot and Feasibility Studies|June 2, 2020
Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndromeKimberly Legault, Mark Blostein, Marc Carrier, et al.
Research and Practice in Thrombosis and Haemostasis|July 10, 2025
Investigating interassay variability between direct oral anticoagulant calibrated anti-factor Xa assays: a substudy of the perioperative anticoagulation use for surgery evaluation (PAUSE) trialRyan M Baker, Rita Selby, Karen A Moffat, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 27, 2023
Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysisRachel Eikelboom, Richard P Whitlock, Raveen Muzaffar, et al.
Journal of Surgical Oncology|April 1, 2022
Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort studySam Schulman, Vanessa Carlson, Pablo E Serrano, et al.
Journal of Internal Medicine|February 14, 2025
Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controlsKatarina Glise Sandblad, Annika Rosengren, Sam Schulman, et al.
Chest|February 9, 2012
Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesLori-Ann Linkins, Antonio L Dans, Lisa K Moores, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulantJames D Douketis, Summer Syed, Na Li, et al.
Thrombosis Research|February 22, 2017
Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort studySam Schulman, B Ritchie, S Nahirniak, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedureJoseph R Shaw, Na Li, Joanne Nixon, et al.
Thrombosis and Haemostasis|June 28, 2016
The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trialKochawan Boonyawat, Luqi Wang, Alejandro Lazo-Langner, et al.
Pageof 31

Showing results (171-180 of 308) with videos related to

Sort By:
Pageof 31
Pilot and Feasibility Studies|June 2, 2020
Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndromeKimberly Legault, Mark Blostein, Marc Carrier, et al.
Research and Practice in Thrombosis and Haemostasis|July 10, 2025
Investigating interassay variability between direct oral anticoagulant calibrated anti-factor Xa assays: a substudy of the perioperative anticoagulation use for surgery evaluation (PAUSE) trialRyan M Baker, Rita Selby, Karen A Moffat, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 27, 2023
Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysisRachel Eikelboom, Richard P Whitlock, Raveen Muzaffar, et al.
Journal of Surgical Oncology|April 1, 2022
Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort studySam Schulman, Vanessa Carlson, Pablo E Serrano, et al.
Journal of Internal Medicine|February 14, 2025
Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controlsKatarina Glise Sandblad, Annika Rosengren, Sam Schulman, et al.
Chest|February 9, 2012
Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesLori-Ann Linkins, Antonio L Dans, Lisa K Moores, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulantJames D Douketis, Summer Syed, Na Li, et al.
Thrombosis Research|February 22, 2017
Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort studySam Schulman, B Ritchie, S Nahirniak, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedureJoseph R Shaw, Na Li, Joanne Nixon, et al.
Thrombosis and Haemostasis|June 28, 2016
The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trialKochawan Boonyawat, Luqi Wang, Alejandro Lazo-Langner, et al.
Pageof 31